Please click here for the U.S. Full Prescribing Information, including Patient Information.
Don't miss this opportunity to learn about COBENFY as a treatment option for your patients. Explore COBENFY's clinical profile, including efficacy, safety, and dosing information. This program also highlights practical considerations when prescribing COBENFY.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Faculty Information
View biographical information
Alberto Augsten, PharmD, MS, BCPP, DABAT
Pharmacy Clinical Manager, Long-Acting Therapy Clinic (LAT) Manager, PGY2 Psychiatric Pharmacy Residency Director, Board Certified Clinical Toxicologist
Memorial Regional Hospital
Hollywood, FL
Learning Objectives
- Explore the persistent challenges and evolving understanding of the disease impacting patients.
- Review the short- and long-term data supporting the efficacy, safety and tolerability profile of COBENFY.
- Review practical considerations when prescribing COBENFY.
Continuing Education Credit and Disclosures
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.